Andrew M. Farland

Race, rituximab, and relapse in TTP

Shruti Chaturvedi, Ana G. Antun, Andrew M. Farland et al. · Blood · 2022 · 39 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Successful treatment of intravenously abused oral Opana ER‐induced thrombotic microangiopathy without plasma exchange

Peter Miller, Andrew M. Farland, Mary Ann Knovich et al. · American Journal of Hematology · 2014 · 22 citations · Full text

Medicine, Pharmacotherapy, Clinical Pharmacology +5

Implementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell Disease

Jena L Welch-Coltrane, Anthony A Wachnik, Meredith C B Adams et al. · Pain Medicine · 2021 · 20 citations · Full text

Nursing, Health Care Management, Outcomes Research +13

Long‐term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements

Mary Ann Knovich, Andrew M. Farland, John D. Owen · European Journal Of Haematology · 2012 · 18 citations

Medicine, Hematology, Immunology +11

Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A

Nadia El-Akabawy, Martin Rodriguez, Ritu M. Ramamurthy et al. · Molecular Therapy — Methods & Clinical Development · 2020 · 16 citations · Full text

Life Sciences, Biotechnology, Genetics +17